{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:35Z","timestamp":1760189195974},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1532,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1600-0609.2011.01626.x","type":"journal-article","created":{"date-parts":[[2011,6,22]],"date-time":"2011-06-22T07:42:56Z","timestamp":1308728576000},"page":"10-19","source":"Crossref","is-referenced-by-count":19,"title":["Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD\/SCID xenograft model"],"prefix":"10.1111","volume":"87","author":[{"given":"Semra","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Grabellus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewin","family":"Eisele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"M\u00f6llmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Hanoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Carpinteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"N\u00fcckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim R.","family":"G\u00f6thert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"D\u00fcrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,22]]},"reference":[{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1158\/0008-5472.CAN-07-1198","article-title":"A novel nonobese diabetic\/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease","volume":"67","author":"D\u00fcrig","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/0008-5472.CAN-08-4136","article-title":"Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow","volume":"69","author":"Hartmann","year":"2009","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1182\/blood-2009-03-213363","article-title":"Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells","volume":"115","author":"Liang","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/1078-0432.CCR-10-0232","article-title":"The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo","volume":"16","author":"Paesler","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2007.06851.x","article-title":"Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model","volume":"139","author":"Scaglione","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood-2009-12-258814","article-title":"HS1 has a central role in the trafficking and homing of leukemic B cells","volume":"116","author":"Scielzo","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","article-title":"The PARP inhibitor olaparib induces significant killing of ATM deficient lymphoid tumour cells in vitro and in vivo","volume":"116","author":"Weston","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2005-12-011213","article-title":"Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia","volume":"108","author":"Johnson","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/0008-5472.CAN-05-3426","article-title":"Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice","volume":"66","author":"Zanesi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"e3192","DOI":"10.1371\/journal.pone.0003192","article-title":"Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice","volume":"3","author":"Schmidt","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02982640","article-title":"Immunodeficient mouse models of lymphoid tumors","volume":"77","author":"Imada","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1182\/blood-2008-01-129726","article-title":"CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?","volume":"111","author":"Aydin","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clim.2009.02.004","article-title":"High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia","volume":"131","author":"Nuckel","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/10428190410001683697","article-title":"B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors","volume":"45","author":"Schroers","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2009-05-219634","article-title":"In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia","volume":"114","author":"Calissano","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2007-04-083832","article-title":"CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells","volume":"110","author":"Damle","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood-2006-01-013003","article-title":"In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia","volume":"108","author":"Deaglio","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2119\/molmed.2009.00146","article-title":"CD38\/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells","volume":"4","author":"Deaglio","year":"2010","journal-title":"Mol Med"},{"key":"10.1111\/j.1600-0609.2011.01626.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/TP.0b013e3181a5cb07","article-title":"Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice","volume":"87","author":"Ito","year":"2009","journal-title":"Transplantation"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2011.01626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0609.2011.01626.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T05:55:51Z","timestamp":1625637351000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2011.01626.x"}},"subtitle":["Role of CD38 in the CLL NOD\/SCID xenograft model"],"short-title":[],"issued":{"date-parts":[[2011,6,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01626.x","relation":{},"ISSN":["0902-4441"],"issn-type":[{"value":"0902-4441","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,22]]}}}